| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.13.12.1738 |
| P698 | PubMed publication ID | 8241093 |
| P2093 | author name string | R Lassila | |
| P Kauhanen | |||
| M Lepäntalo | |||
| V Manninen | |||
| O Saarinen | |||
| S Peltonen | |||
| P433 | issue | 12 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 1738-1742 | |
| P577 | publication date | 1993-12-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin | |
| P478 | volume | 13 |
| Q35829481 | A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice |
| Q74397645 | Activation of coagulation and fibrinolysis after rehabilitative exercise in patients with coronary artery disease |
| Q73251661 | Activation of thrombosis and fibrinolysis following brain infarction |
| Q78095095 | Argatroban increases nitric oxide levels in patients with peripheral arterial obstructive disease: placebo-controlled study |
| Q24808644 | Blood coagulation and the risk of atherothrombosis: a complex relationship |
| Q96125121 | COVID-19 and SIC (!) |
| Q47833058 | D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy |
| Q73295856 | Effect of Thrombin Inhibition on Patients with Peripheral Arterial Obstructive Disease: A Multicenter Clinical Trial of Argatroban |
| Q35120065 | Factors associated with D-dimer levels in HIV-infected individuals |
| Q35221823 | Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator |
| Q40409553 | Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia |
| Q74292655 | Fibrinogen in rat gastrointestinal lymph before, during and after intraduodenal administration of emulsified triglyceride: fibrinogen bound to chylomicrons in gastrointestinal lymph is functional |
| Q73637155 | Fibrinogen is an efficient antioxidant |
| Q35788722 | Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse |
| Q34297119 | Gender-specific risk factors for peripheral artery disease in a voluntary screening population |
| Q33581345 | Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case-Control Study |
| Q74292638 | Markers of inflammation and hypercoagulability in diabetic and nondiabetic patients with lower extremity ischemia |
| Q73022835 | Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d'Etude |
| Q35021902 | Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation |
| Q36129316 | Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts |
| Q47762914 | Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication |
| Q83856241 | The role of coagulation and inflammation after angioplasty in patients with peripheral arterial disease |
| Q37240386 | Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate? |
Search more.